Immunogenic composition containing rabbit staphylococcal antigen, and preparation method and application thereof
A technology of rabbit staphylococcus and staphylococcus, which is applied in the field of veterinary biological products, can solve the problems of storage space, vaccine strain failure, and reduced protection rate, and achieve the effect of easy storage, high porosity, and guaranteed firmness
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0029] (1) Preparation of Rabbit Staphylococcus Antigens
[0030] 1) Resuscitate the intestinal bacteria and respiratory bacteria isolated and cultured from the liver and lungs of dead rabbits infected with Staphylococcus aureus as bacterial strains. After passing the pure bacteria inspection, inoculate the two bacterial strains into ordinary broth medium respectively, Incubate at 37°C for 20 hours to make a bacterial solution with a predetermined concentration;
[0031] 2) Use turbidimetry and ultraviolet spectrophotometry to determine the concentration of respiratory tract bacteria to be 300 million / mL, add formaldehyde solution at 0.3% of the amount of bacteria solution, and inactivate at 37°C for 20 hours; determine the concentration of intestinal bacteria to be 1 billion / mL mL, first bathed at 100°C for 2.5h, then add 0.3% formaldehyde solution to inactivate at 37°C for 20h;
[0032] 3) Inoculate the intestinal bacteria and respiratory bacteria treated in step 2) on the ...
Embodiment 2
[0043] This embodiment is basically the same as Embodiment 1, the difference is:
[0044] The dispersion carrier in this embodiment is chitosan nanoparticles loaded with dispersin B. Disperse protein B can promote the overall diffusion of biofilm, and is beneficial to disperse and release rabbit staphylococcus antigenic strains.
[0045] The preparation method of the disperse carrier is as follows: add the dispersin B solution to the chitosan acetic acid solution with a concentration of 4.0mg / ml until the final concentration of the dispersin B is 2.0mg / ml, under the condition of 30-35℃ and magnetic stirring Mix well, let stand at 25°C for 22 hours, add phosphate ester with a final concentration of 1.5mg / ml under the condition of 200rpm low-speed magnetic stirring, to activate chitosan nanoparticle, and facilitate the loading of dispersin B, keep stirring for 35 minutes, The obtained chitosan nanoparticle loaded with dispersin B has the characteristic of firm loading of dispers...
Embodiment 3
[0051] This embodiment is basically the same as Embodiment 2, the difference is:
[0052] The aqueous printing adjuvant of the present embodiment adopts commercially available Montanide TM Gel's aqueous vaccine adjuvant.
PUM
Property | Measurement | Unit |
---|---|---|
Thickness | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com